Literature DB >> 29884897

Roundup litigation discovery documents: implications for public health and journal ethics.

Sheldon Krimsky1, Carey Gillam2.   

Abstract

This paper reviews the court-released discovery documents obtained from litigation against Monsanto over its herbicide Roundup and through Freedom of Information Act requests (requests to regulatory agencies and public universities in the United States). We sought evidence of corporate malfeasance and undisclosed conflicts of interest with respect to issues of scientific integrity. The findings include evidence of ghostwriting, interference in journal publication, and undue influence of a federal regulatory agency.

Keywords:  EPA; Ghost writing; Glyphosate; IARC; Monsanto; Roundup

Mesh:

Substances:

Year:  2018        PMID: 29884897     DOI: 10.1057/s41271-018-0134-z

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  3 in total

Review 1.  Scientific integrity issues in Environmental Toxicology and Chemistry: Improving research reproducibility, credibility, and transparency.

Authors:  Christopher A Mebane; John P Sumpter; Anne Fairbrother; Thomas P Augspurger; Timothy J Canfield; William L Goodfellow; Patrick D Guiney; Anne LeHuray; Lorraine Maltby; David B Mayfield; Michael J McLaughlin; Lisa S Ortego; Tamar Schlekat; Richard P Scroggins; Tim A Verslycke
Journal:  Integr Environ Assess Manag       Date:  2019-02-28       Impact factor: 2.992

Review 2.  Trans-disciplinary diagnosis for an in-depth reform of regulatory expertise in the field of environmental toxicology and security.

Authors:  Joël Spiroux de Vendômois; Jean-Paul Bourdineaud; Arnaud Apoteker; Nicolas Defarge; Emilie Gaillard; Corinne Lepage; Jacques Testart; Christian Vélot
Journal:  Toxicol Res       Date:  2021-01-25

3.  Regulation of genetically engineered (GE) mosquitoes as a public health tool: a public health ethics analysis.

Authors:  Zahra Meghani
Journal:  Global Health       Date:  2022-02-21       Impact factor: 4.185

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.